Transient disappearance of CD19
CD19+/CD5+ clone
SARS‐CoV‐2
lymphocytic leukemia
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
revised:
12
04
2021
accepted:
14
04
2021
entrez:
30
6
2021
pubmed:
1
7
2021
medline:
1
7
2021
Statut:
epublish
Résumé
Although lymphopenia is currently considered a good predictor for the prognosis of COVID-19, it must be critically evaluated in patients with CLL, where other clinical markers should be considered to define the prognosis and treatment.
Identifiants
pubmed: 34188925
doi: 10.1002/ccr3.4238
pii: CCR34238
pmc: PMC8218322
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e04238Informations de copyright
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
None declared.
Références
Leukemia. 2020 Nov;34(11):3047-3049
pubmed: 32855439
Br J Haematol. 2021 Feb;192(3):415
pubmed: 33386647
Int J Infect Dis. 2020 Jul;96:131-135
pubmed: 32376308
Intern Med J. 2020 Jun;50(6):667-679
pubmed: 32415723
Blood. 2015 Jul 30;126(5):573-81
pubmed: 26084672
Br J Haematol. 2020 Aug;190(4):e187-e189
pubmed: 32557555
Hematol Transfus Cell Ther. 2020 Apr - Jun;42(2):103-110
pubmed: 32313873
Blood. 2020 Sep 3;136(10):1134-1143
pubmed: 32688395
Front Immunol. 2020 Jun 05;11:1294
pubmed: 32582221
JAMA Oncol. 2020 Oct 1;6(10):1529-1530
pubmed: 32433719
Lancet Haematol. 2020 Apr;7(4):e351-e352
pubmed: 32220344
Int J Lab Hematol. 2020 Aug 9;:
pubmed: 32881278
PLoS One. 2020 Nov 18;15(11):e0241659
pubmed: 33206680
Leukemia. 2020 Sep;34(9):2354-2363
pubmed: 32647324
Immunol Lett. 2020 Sep;225:31-32
pubmed: 32569607
Acta Biomed. 2020 Sep 07;91(3):e2020008
pubmed: 32921706
Blood. 2020 Aug 6;136(6):763-766
pubmed: 32559271
Semin Immunol. 2014 Feb;26(1):38-47
pubmed: 24602448
Leuk Res. 2020 Jun;93:106366
pubmed: 32388230